CHRISTIANNA FINN: Open Payments
NPI 1417661489 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $180 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $245 |
| Exact Sciences Corporation | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| Boston Scientific Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Amgen Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: FARXIGA, JARDIANCE, WATCHMAN FLX, MOUNJARO, Cologuard Collection Kit, OTEZLA, REXULTI, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
